Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
Are your patients with obesity struggling to lose weight through diet and exercise alone? The non-surgical ESG procedure can significantly reduce your patient s stomach capacity to help them feel full sooner – which may lead to lasting weight loss when combined with diet and lifestyle changes1.
See ESG procedure product information at bottom of page.
In a clinical trial, people experienced 13.6% total body weight loss (TBWL) one year after the ESG procedure when combined with diet and lifestyle changes1.
In the same clinical trial, 68% of people maintained 25% excessive weight loss (EWL) two years after the ESG procedure1.
Register now to gain access to clinical tools and patient resources for ESG and other endobariatric procedures.
Dr. Brian Dunkin explains how endobariatric procedures can help fill the gap between lifestyle modifications and surgery – even with the growth of GLP-1 medications – for people living with obesity. Register to access
Dr. Brian Dunkin explores why a leading bariatric surgery society now recognizes ESG as an effective option within the obesity treatment pathway, based on a review of evidence across 44 studies and 15,000+ patients. Register to access
Make sure your patients have the information they need on their weight loss journey.
Expand your endobariatric offerings with clinical summaries, dietary guidebooks, and patient brochures in both English and Spanish.
If you’ve previously registered for resources, go to your inbox for the confirmation email from Boston Scientific.
Explore Boston Scientific’s health economics and reimbursement resources, including the Bariatric Surgical Medical Necessity Guide as well as updated information on CPT® and ICD-10 codes, physician RVUs, and Medicare national average reimbursement rates for endobariatric procedures.
Explore EDUCARE on-demand courses and product training on endobariatric procedures.
OverStitch™ Endoscopic Suturing System ESS Indications, Safety, and Warnings
OverStitch NXT™ Endoscopic Suturing System ESS Indications, Safety, and Warnings
OverStitch™ 2-0 Polypropylene Suture Assembly Indications, Safety, and Warnings
*As a condition of the FDA De Novo Authorization of the OverStitch NXT and OverStitch Endoscopic Suturing System for endobariatric procedures (formerly referred to as the Apollo ESG and Apollo REVISE Systems), the devices should only be used for endoscopic sleeve gastroplasty (ESG) or to enable transoral outlet reduction (TORe) as a bariatric revision procedure by gastroenterologists and surgeons who have undergone specific training by the device manufacturer. To fulfill the FDA requirement and special controls for these devices, Boston Scientific is required to independently host courses with consistent training curricula. More information regarding the referenced ESG and TORe revision procedure training courses is available through Boston Scientific.
Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider's responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered. Boston Scientific recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label.
1. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All photographs taken by Boston Scientific.
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
